Latest Articles
PRM Endometriosis Specialist Dr. Reza Askari Featured on - GlobeNewswire
PRM Endometriosis Specialist Dr. Reza Askari Featured on GlobeNewswire
Published: July 31, 2026, 3:47 p.m.
PRM Endometriosis Specialist Dr. Reza Askari Featured on Nancy's Nook Educational Resource for Endometriosis Patients - Yahoo Finance Singapore
PRM Endometriosis Specialist Dr. Reza Askari Featured on Nancy's Nook Educational Resource for Endometriosis Patients Yahoo Finance Singapore
Published: July 31, 2026, 3:47 p.m.
PRM Endometriosis Specialist Dr. Reza Askari Featured on Nancy's Nook Educational Resource for Endometriosis Patients - Yahoo Finance
PRM Endometriosis Specialist Dr. Reza Askari Featured on Nancy's Nook Educational Resource for Endometriosis Patients Yahoo Finance
Published: July 31, 2026, 3:47 p.m.
PRM Endometriosis Specialist Dr. Reza Askari Featured on Nancy's Nook Educational Resource for Endometriosis Patients - finance.yahoo.com
PRM Endometriosis Specialist Dr. Reza Askari Featured on Nancy's Nook Educational Resource for Endometriosis Patients finance.yahoo.com
Published: July 31, 2026, 3:47 p.m.
Small cap wrap: Medicus Pharma, Tiziana Life Sciences, Namibia Critical Metals... - Proactive Investors
Small cap wrap: Medicus Pharma, Tiziana Life Sciences, Namibia Critical Metals... Proactive Investors
Published: July 31, 2026, 3:30 p.m.
Medicus Pharma receives UAE approval for Phase 2a Endometriosis trial - Proactive financial news
Medicus Pharma receives UAE approval for Phase 2a Endometriosis trial Proactive financial news
Published: July 31, 2026, 3:20 p.m.
Medicus Pharma receives UAE approval for Phase 2a Endometriosis trial - Yahoo Finance UK
Medicus Pharma receives UAE approval for Phase 2a Endometriosis trial Yahoo Finance UK
Published: July 31, 2026, 3:09 p.m.
Selinexor Misses PFS End Point in TP53 Wild-Type Endometrial Cancer - CancerNetwork
Selinexor Misses PFS End Point in TP53 Wild-Type Endometrial Cancer CancerNetwork
Published: July 31, 2026, 2:37 p.m.
Selinexor Misses PFS End Point in TP53 Wild-Type Endometrial Cancer - cancernetwork.com
Selinexor Misses PFS End Point in TP53 Wild-Type Endometrial Cancer cancernetwork.com
Published: July 31, 2026, 2:37 p.m.
Absci Maintained at Buy as Yazdi Highlights ABS-201’s Dual Alopecia and Endometriosis Upside; $13 Price Target Unchanged - TipRanks
Absci Maintained at Buy as Yazdi Highlights ABS-201’s Dual Alopecia and Endometriosis Upside; $13 Price Target Unchanged TipRanks
Published: July 31, 2026, 2:09 p.m.
Link copied to clipboard!